Chaitan S. Khosla
Director/Board Member at FIRST WAVE BIOPHARMA, INC.
Net worth: 1 201 $ as of 29/04/2024
Chaitan S. Khosla active positions
| Companies | Position | Start | End |
|---|---|---|---|
| FIRST WAVE BIOPHARMA, INC. | Director/Board Member | 12/03/2024 | - |
| Independent Dir/Board Member | 12/03/2024 | - | |
| Stanford University | Corporate Officer/Principal | 31/12/2000 | - |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Corporate Officer/Principal | - | - |
National Academy of Engineering
 National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The private company is based in Washington. | Corporate Officer/Principal | - | - |
Protagonist Pty Ltd.
 Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Director/Board Member | - | - |
| Independent Dir/Board Member | - | - | |
| Stanford Chem-H | Corporate Officer/Principal | 31/12/2012 | - |
Career history of Chaitan S. Khosla
Former positions of Chaitan S. Khosla
| Companies | Position | Start | End |
|---|---|---|---|
ImmunogenX LLC
 ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Director/Board Member | 31/12/2020 | 12/03/2024 |
| PROTAGONIST THERAPEUTICS, INC. | Director/Board Member | 30/09/2014 | 10/08/2020 |
| Independent Dir/Board Member | 30/09/2014 | 10/08/2020 | |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Director/Board Member | 13/09/2009 | 31/12/2015 |
| Chairman | 31/12/2004 | 13/09/2009 | |
| Founder | 31/12/2004 | 31/12/2015 | |
| ░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░ ░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░ | ░░░░░░░░░░ | - |
Training of Chaitan S. Khosla
| California Institute of Technology | Doctorate Degree |
| Indian Institute of Technology Bombay | Undergraduate Degree |
Statistics
International
| United States | 13 |
| Australia | 2 |
| India | 2 |
Operational
| Director/Board Member | 6 |
| Founder | 4 |
| Corporate Officer/Principal | 4 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| PROTAGONIST THERAPEUTICS, INC. | Health Technology |
| FIRST WAVE BIOPHARMA, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Health Technology |
Alvine Pharmaceuticals, Inc.
Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Alvine Pharmaceuticals, Inc. develops and commercializes therapeutics for inflammatory diseases. It offers ALV003, tTG Inihibitors and HLA-DQ2 Blockers. The company was founded by Blair Stewart and Kevin R. Kaster in 2005 and is headquartered in San Carlos, CA. | Health Technology |
Protagonist Pty Ltd.
Protagonist Pty Ltd. Pharmaceuticals: MajorHealth Technology Protagonist Pty Ltd. operates as a clinical-stage biopharmaceutical company. Its proprietary technology platform focused on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded on September 19, 2001 and is headquartered in Brisbane, Australia. | Health Technology |
American Academy of Arts & Sciences
American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Commercial Services |
National Academy of Engineering
National Academy of Engineering Miscellaneous Commercial ServicesCommercial Services Part of The National Academies of Science, the National Academy of Engineering operates as a professional membership organization. The private company is based in Washington. | Commercial Services |
| Celiac Sprue Research Foundation Corp. | |
Sitari Pharma, Inc.
 Sitari Pharma, Inc. BiotechnologyHealth Technology Sitari Pharma, Inc. provides pharmaceutical research and development services. It engages in multiple disease indications such as celiac disease. The company was founded by Chaitan S. Khosla and Thomas DiRaimondo in 2013 and is headquartered in La Jolla, CA. | Health Technology |
ImmunogenX LLC
ImmunogenX LLC BiotechnologyHealth Technology ImmunogenX LLC develops diagnosis and treatment for autoimmune and gastrointestinal diseases. It focuses on therapy, disease management, and food safety. The company was founded by Jack A. Syage and Jennifer A. Sealey-Voyksner in 2013 and is headquartered in Newport Beach, CA. | Health Technology |
| Stanford Chem-H |
- Stock Market
- Insiders
- Chaitan S. Khosla
- Experience
